Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.
Publication
, Journal Article
Fraiche, A; Wang, A
Published in: Curr Cardiol Rep
July 2016
Since publication of the 2011 American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy (HCM), more recent studies offer greater insights about this condition. With increased recognition of the role of sarcomere protein mutations and myocardial structural abnormalities in the pathophysiology of this disease, new evidence offers potential improvements for the management of patients with HCM. In this review of studies published since 2011, we highlight several studies that may impact diagnostic considerations, risk stratification, and treatment of symptoms in HCM.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Curr Cardiol Rep
DOI
EISSN
1534-3170
Publication Date
July 2016
Volume
18
Issue
8
Start / End Page
70
Location
United States
Related Subject Headings
- United States
- Risk Factors
- Risk Assessment
- Practice Guidelines as Topic
- Myocardium
- Magnetic Resonance Imaging
- Humans
- Death, Sudden, Cardiac
- Cardiovascular System & Hematology
- Cardiomyopathy, Hypertrophic
Citation
APA
Chicago
ICMJE
MLA
NLM
Fraiche, A., & Wang, A. (2016). Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline. Curr Cardiol Rep, 18(8), 70. https://doi.org/10.1007/s11886-016-0751-8
Fraiche, Ariane, and Andrew Wang. “Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.” Curr Cardiol Rep 18, no. 8 (July 2016): 70. https://doi.org/10.1007/s11886-016-0751-8.
Fraiche A, Wang A. Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline. Curr Cardiol Rep. 2016 Jul;18(8):70.
Fraiche, Ariane, and Andrew Wang. “Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.” Curr Cardiol Rep, vol. 18, no. 8, July 2016, p. 70. Pubmed, doi:10.1007/s11886-016-0751-8.
Fraiche A, Wang A. Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline. Curr Cardiol Rep. 2016 Jul;18(8):70.
Published In
Curr Cardiol Rep
DOI
EISSN
1534-3170
Publication Date
July 2016
Volume
18
Issue
8
Start / End Page
70
Location
United States
Related Subject Headings
- United States
- Risk Factors
- Risk Assessment
- Practice Guidelines as Topic
- Myocardium
- Magnetic Resonance Imaging
- Humans
- Death, Sudden, Cardiac
- Cardiovascular System & Hematology
- Cardiomyopathy, Hypertrophic